Overexpression of choline kinase has been shown to increase functional interaction between EGFR and mTORC2 for Akt activation, promoting HCC metastasis and treatment resistance to EGFR inhibitors gefitinib and erlotinib [44]. This evidence concerns the gene EGFR and hepatocellular carcinoma.